What did Henry Schein, Inc. pay for Biotech Dental?

Henry Schein, Inc. acquired Biotech Dental for $496.0M in 2023, equivalent to 5.00x revenue. Target revenue was approximately $100.0M.

What does Biotech Dental do?

Biotech Dental is a dental practice business.

What multiple did Henry Schein, Inc. pay for Biotech Dental?

5.00x revenue, based on disclosed deal value of $496.0M and disclosed financials.

M&A TRANSACTION · 2023

Biotech Dental acquired by Henry Schein, Inc.

$496.0M· 5.00x revenue

Target

Biotech Dental

Acquirer

Henry Schein, Inc.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$100.0M

EBITDA

—

Deal Value

$496.0M

EV/EBITDA

—

Context

This $496.0M acquisition of Biotech Dental by Henry Schein, Inc. sits in the dental practice sub-vertical. Henry Schein, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price dental practice businesses on our Dental Practice strategic buyer-pool page.

Source

Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own dental practice

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Biotech Dental acquisition.

Citation: ExitValue.ai. (2023). Biotech Dental acquired by Henry Schein, Inc.. https://exitvalue.ai/deals/biotech-dental-acquired-by-henry-schein-inc-hc-2023-0049